ART-CARMA Clinical Study part of 6m Euro global programme
medication adherence) project, led by a research team at King’s College London, will use real-time data, gathered over 12 months, with a long term aim of improving the management of cardiometabolic disease in adults with ADHD, and to improve ADHD medication treatment adherence and the personalisation of treatment. ART-CARMA forms a part of TIMESPAN, a 5-year-long, collaborative and multidisciplinary research programme with 17 partner institutions across Europe and the world, including academia, small and medium-sized enterprises (SMEs), patients and care providers. The programme launched o...
Source: miragenews.com